Lincoln Pharmaceuticals Limited
₹616.85
INR-12.75(-2.03%)
As of November 14, 2024 10:00:00 AMValuation Metrics
Market Cap
Total market value of the company's outstanding shares
₹1364.72 Cr
Enterprise Value
Total value of the company including debt and excluding cash
₹1197.03 Cr
P/E Ratio (TTM)
Price to Earnings ratio based on trailing 12 months
13.94
Forward P/E
Price to Earnings ratio based on forecasted earnings
NA
PEG Ratio
Price/Earnings to Growth ratio
NA
Price to Sales (TTM)
Price to Sales ratio based on trailing 12 months
2.30
Financial Metrics
Gross Margin
Gross profit as a percentage of revenue
52.31%
Operating Margin
Operating income as a percentage of revenue
13.25%
Return on Equity
Net income as a percentage of shareholders' equity
15.74%
Revenue (TTM)
Total revenue over trailing 12 months
₹592.21 Cr+8.6%
EBITDA
Earnings Before Interest, Taxes, Depreciation, and Amortization
₹139.06 Cr
EPS (TTM)
Earnings Per Share over trailing 12 months
₹48.89+24.5%
Balance Sheet
Total Cash
Total cash and short-term investments
₹152.75 Cr
Total Debt
Total short-term and long-term debt
₹1.07 Cr
Debt to Equity
Total debt as a percentage of shareholders' equity
0.18%
Stock Information
52 Week Range
Lowest and highest stock price over the past 52 weeks
₹476.3 - ₹811.85
Beta
Measure of stock's volatility compared to the market
0.68
Shares Outstanding
Total number of shares issued by the company
₹2.00 Cr
Dividends & Splits
Forward Dividend Yield
Expected dividend yield based on forward dividend rate
1.06%
Trailing Dividend Yield
Dividend yield based on trailing 12 months
0.00%
Payout Ratio
Percentage of earnings paid as dividends
3.07%